Menu

BeyondSPX has rebranded as EveryTicker. We now operate at everyticker.com, reflecting our coverage across nearly all U.S. tickers. BeyondSPX has rebranded as EveryTicker.

Morgan Stanley Direct Lending Fund (MSDL)

$14.81
-0.66 (-4.27%)
Get curated updates for this stock by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.

Data provided by IEX. Delayed 15 minutes.

Company Profile

Price Chart

Loading chart...

At a glance

Defensive Quality as Differentiation: MSDL's 96.3% first-lien portfolio, Morgan Stanley (MS) franchise access, and selective underwriting have produced credit quality that materially exceeds peers (120bps non-accruals vs. industry averages near 2%), but this risk-averse approach translates into slower deployment and questions about growth scalability.

Liability Optimization Inflection Point: The September 2025 inaugural CLO ($401M at SOFR+1.70%) and ABL repricing (30bps reduction to SOFR+1.95%) deliver an estimated $0.01/share earnings benefit starting Q4 2025, partially offsetting the 25.5% decline in quarterly NII caused by base rate cuts and portfolio repricing.

M&A Recovery Narrative vs. Execution Reality: Management anticipates a multi-year M&A recovery driven by $2.8 trillion in private equity dry powder, yet MSDL's deployment remains selective (over 90% of new borrowers led/co-led) while larger peers like Ares Capital (ARCC) and Blue Owl Credit Income (OBDC) capture more market share through scale advantages.